How big is the rosacea market today, and what are its future growth expectations?
The rosacea market size has grown strongly in recent years. It will grow from $1.95 billion in 2024 to $2.15 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to growing awareness of rosacea, increasing access to healthcare, rising disposable incomes, government support for rosacea research and treatment, .
The rosacea market size is expected to see strong growth in the next few years. It will grow to $3.02 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to biologic therapies, demand for personalized medicine, aging population, increasing prevalence of comorbidities. Major trends in the forecast period include minimally invasive and non-invasive treatments for rosacea, digital health technologies, rosacea-specific cosmetics, non-invasive therapies.
Get Your Free Sample of The Global Rosacea Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12945&type=smp
What are the top drivers to the rising demand in the rosacea market?
The increasing prevalence of skin diseases is expected to propel the growth of the rosacea market going forward. Skin diseases are medical conditions that affect the skin’s appearance, structure and function. These conditions can involve the skin, hair, nails and related tissues. Rosacea, a type of inflammation and skin problem, can be caused by various fungal infections, including overgrowth of Candida. Moreover, rosacea has a statistically significant increased risk of skin cancers such as hepatic cancer, non-melanoma skin cancer and breast cancer. For instance, in February 2023, according to Cancer Research UK, a UK-based cancer research organization, the average number of new melanoma skin cancer cases each year in the UK is expected to increase from approximately 20,800 cases in 2023-2025 to around 26,500 cases in 2038-2040. This represents a projected 9% rise in melanoma incidence rates, reaching 33 cases per 100,000 people annually by 2038-2040. Therefore, the increasing prevalence of skin diseases is driving the growth of the rosacea market.
How is the rosacea market segmented?
The rosacea market covered in this report is segmented –
1) By Type: Erythematotelangiectatic Rosacea, Papulopustular Rosacea, Ocular Rosacea, Phymatous Rosacea
2) By Drug Class: Antibiotics, Alpha Agonists, Retinoid, Corticosteroids, Immunosuppressants, Other Drug Classes
3) By Mode of Administration: Topical, Oral
4) By End-User: Hospitals, Clinics, Retail pharmacies, Online pharmacies
Subsegments:
1) By Erythematotelangiectatic Rosacea: Persistent Facial Redness, Visible Blood Vessels
2) By Papulopustular Rosacea: Red Bumps, Pus-Filled Pimples
3) By Ocular Rosacea: Eye Irritation, Inflammation Of Eyelids, Dry Eyes
4) By Phymatous Rosacea: Rhinophyma, Thickened Skin On The Face
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/rosacea-global-market-report
Who are the top competitors in the rosacea market?
Major companies operating in the rosacea market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline PLC, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Galderma S.A., Dr. Reddy’s Laboratories Ltd., Lupin Limited, LEO Pharma A/S, Almirall S.A., Supernus Pharmaceuticals Inc., Taro Pharmaceuticals, Mayne Pharma, Aclaris Therapeutics Inc., Sol-Gel Technologies Ltd., Nestle Skin Health S.A., Foamix Pharmaceuticals.
What significant trends should we anticipate in the rosacea market over the forecast period?
Major companies operating in the rosacea market are integrating their efforts into developing novel products and solutions to sustain their position in the market. For instance, in June 2022, Galderma S.A., a Switzerland-based pharmaceutical company, launched EPSOLAY cream, the first and only topical treatment with microencapsulated benzoyl peroxide (E-BPO) that is scientifically proven to alleviate bumps and blemishes caused by rosacea. EPSOLAY Cream uses Sol-Gel Technology’s proprietary, patented technology to encapsulate benzoyl peroxide in a silica-based microcapsule to form a barrier between the medication and the skin surface. This helps to reduce the irritation and dryness that can be associated with traditional benzoyl peroxide treatments.
Which regional trends are influencing the rosacea market, and which area dominates the industry?
North America was the largest region in the rosacea market in 2024. Asia-Pacific is expected to the fastest-growing region in the forecast period. The regions covered in rosacea market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The Rosacea Market Report 2025 Offer?
The rosacea market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Rosacea is a chronic skin disorder that primarily affects the face and causes reddened skin, flushing and bumps, usually on the cheeks and nose. It typically develops in adulthood and is more common in fair-skinned individuals. Rosacea symptoms include swollen red bumps, visible blood vessels and pus-filled pimples.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12945
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
